RenovoRx Inc.

NASDAQ: RNXT · Real-Time Price · USD
0.98
-0.26 (-20.97%)
At close: Aug 15, 2025, 1:09 PM

RenovoRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
43K n/a n/a n/a
Cost of Revenue
n/a n/a 6K 9K
Gross Profit
43K n/a -6K -9K
Operating Income
-10.97M -11.4M -9.95M -5.67M
Interest Income
n/a n/a 57K n/a
Pretax Income
-8.81M -10.23M -9.89M -6.32M
Net Income
-8.81M -10.23M -9.77M -7.1M
Selling & General & Admin
4.99M 5.73M 5.65M 2.63M
Research & Development
6.03M 5.67M 4.3M 3.04M
Other Expenses
n/a n/a 61K n/a
Operating Expenses
11.01M 11.4M 9.95M 5.67M
Interest Expense
384K 108K 57K 834K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
11.01M 11.4M 9.95M 5.67M
Income Tax Expense
n/a n/a -118K 772K
Shares Outstanding (Basic)
23.61M 20.58M 18.1M 17.87M
Shares Outstanding (Diluted)
23.61M 20.58M 18.1M 17.87M
EPS (Basic)
-0.37 -0.5 -0.54 -0.4
EPS (Diluted)
-0.37 -0.5 -0.54 -0.4
EBITDA
-10.97M -11.39M -9.94M -5.66M
EBIT
-10.97M -10.23M -9.95M -5.67M
Depreciation & Amortization
n/a 6K 6K 9K